Back

The utility of a novel echocardiographic prediction model in prognostication of patients with light chain (AL) cardiac amyloidosis

8 December 2017 (12:45 - 13:45)
Organised by:
Congress Presentation Part of: New secrets revealed about cardiomyopathies Restrictive cardiomyopathies EACVI Premium Access EuroEcho-Imaging 2017

About the speaker

Photo
Doctor Muthiah Subramanian

AIG Hospitals, Hyderabad (India)

7 More presentations in this session

Presentation thumbnail
Severe functional mitral regurgitation in dilated cardiomyopathy linked to more pronounced alterations in left ventricular twist mechanics.
Associate Professor E. Kinova (Sofia, BG)
Abstract
Presentation thumbnail
2D-Speckle Tracking Echocardiography in Patients with acute cellular Rejection after orthotopic heart transplantation
Doctor B. Schulze (Bad Oeynhausen, DE)
Abstract Slides
Presentation thumbnail
Morbi-mortality in hypertrophic cardiomyopathy beyond sudden cardiac death - new clinical, imaging and genetic predictors and integration with novel scores
Doctor A. Gomes (Almada, PT)
Abstract
Presentation thumbnail
Right ventricular morphology and function in left ventricular non-compaction cardiomyopathy
Doctor S. Stampfli (Lucerne, CH)
Abstract
Presentation thumbnail
Prognostic implications of severe left ventricular systolic dysfunction at admission in patients with Takotsubo syndrome
Doctor R. Citro (Campobasso, IT)
Abstract Slides

Access the full session

Session thumbnail
New secrets revealed about cardiomyopathies

The Event

Event poster

EuroEcho-Imaging 2017

8 December 2017 12:45 CET
You may be interested in
thumbnail
Congress Presentation
Derivation and validation of a novel prognostic model for patients with light chain (AL) cardiac amyloidosis
29 June 2021
thumbnail
Webinar
Diagnosing and treating cardiac amyloidosis
17 November 2022
thumbnail
Congress Presentation
Left ventricular diastolic dysfunction in cardiac amyloidosis versus true heart failure with preserved ejection fraction
11 May 2024
thumbnail
Congress Presentation
Implementation of the european society cardiac amyloidosis diagnostic algorithm for transthyretin amyloid cardiomyopathy: First real-world data on a heart failure unit in Colombia.
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources